Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,528 | 38,344 | 25,180 | 41,918 | 39,201 |
| Receivables | 523 | 372 | 366 | 526 | 10,496 |
| Other current assets | 4,602 | 4,604 | 4,243 | 4,072 | 0 |
| TOTAL | $44,076 | $49,893 | $37,597 | $51,691 | $58,131 |
| Non-Current Assets | |||||
| PPE Net | 14,794 | 15,733 | 16,877 | 17,887 | 19,146 |
| Other Non-Current Assets | 29,773 | 31,932 | 31,692 | 32,057 | 33,986 |
| TOTAL | $44,567 | $47,665 | $48,569 | $49,944 | $53,132 |
| Total Assets | $88,643 | $97,558 | $86,166 | $101,635 | $111,263 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,556 | 10,740 | 18,204 | 15,485 | 19,791 |
| Accrued Expenses | 17,145 | 15,425 | 14,005 | 14,569 | 10,961 |
| TOTAL | $50,125 | $47,659 | $49,562 | $45,805 | $43,161 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,556 | 7,556 | 7,556 | 7,556 | 774 |
| Other Non-Current Liabilities | 26,401 | 24,423 | 25,809 | 27,186 | 28,968 |
| TOTAL | $32,275 | $30,297 | $31,698 | $33,060 | $28,968 |
| Total Liabilities | $82,400 | $77,956 | $81,260 | $78,865 | $72,129 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 336,495 | 301,710 | 233,167 | 224,710 | 208,647 |
| Common Shares | 3,220 | 2,728 | 2,254 | 2,128 | 2,086 |
| Retained earnings | -1,589,830 | -1,554,900 | -1,534,914 | -1,504,317 | -1,480,921 |
| Other shareholders' equity | -1,445 | -1,459 | -5,527 | -7,530 | -4,223 |
| TOTAL | $6,243 | $19,602 | $4,906 | $22,770 | $39,134 |
| Total Liabilities And Equity | $88,643 | $97,558 | $86,166 | $101,635 | $111,263 |